Table 3.

Diabetes medication changes

Medication Class	n	Deprescribed	Increased	Lowered	No Change
Pharm-TCR
DPP4 Inhibitors	6	6 (100%)	0 (0%)	0 (0%)	0 (0%)
GLP1 Agonists	3	1 (33%)	0 (0%)	0 (0%)	2 (67%)
Insulin	3	1 (33%)	0 (0%)	2 (67%)	0 (0%)
Metformin	19	8 (42%)	0 (0%)	8 (42%)	3 (16%)
SGLT2 Inhibitors	5	4 (80%)	0 (0%)	1 (20%)	0 (0%)
Sulfonylureas	8	8 (100%)	0 (0%)	0 (0%)	0 (0%)
Thiazolidinediones	1	1 (100%)	0 (0%)	0 (0%)	0 (0%)
TAU
DPP4 Inhibitors	0	0 (0%)	0 (0%)	0 (0%)	0 (0%)
GLP1 Agonists	4	0 (0%)	0 (0%)	0 (0%)	4 (100%)
Insulin	3	0 (0%)	0 (0%)	0 (0%)	3 (100%)
Metformin	13	0 (0%)	1 (8%)	0 (0%)	12 (92%)
SGLT2 Inhibitors	1	0 (0%)	0 (0%)	0 (0%)	1 (100%)
Sulfonylureas	2	0 (0%)	1 (50%)	0 (0%)	1 (50%)
Thiazolidinediones	0	0 (0%)	0 (0%)	0 (0%)	0 (0%)

Medication changes are denoted as percentages of participants who were taking each respective medication at baseline. DPP4 Dipeptidyl peptidase-4, GLP1 Glucagon-like peptide-1, SGLT2 Sodium-glucose transport protein 2